Epigenetics and the developmental origins of inflammatory bowel diseases

Canadian Journal of Gastroenterology

Volumn 26, Issue 12, 2012, Pages 909-915

  Kellermayer, Richard ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Diet; DNA methylation; Epigenetics; Inflammatory bowel disease; Microbiome

Indexed keywords

BETA DEFENSIN 2; CXCL16 CHEMOKINE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; DNA METHYLTRANSFERASE; HISTONE H3; HISTONE H4; MICRORNA; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR NRF2; UNTRANSLATED RNA;

BIOMICS; CELIAC DISEASE; CROHN DISEASE; DNA METHYLATION; DNA MODIFICATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; GENE LOCUS; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HISTONE MODIFICATION; HUMAN; INTESTINE FLORA; IRRITABLE COLON; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; ULCERATIVE COLITIS; XENOBIOTIC STRESS;

EID: 84871070315     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/526408     Document Type: Review

References (94)

1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.
2. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011;140:1785-94.
3. Halfvarson J. Genetics in twins with Crohn's disease: Less pronounced than previously believed? Inflamm Bowel Dis 2011;17:6-12.
4. Petronis A, Petroniene R. Epigenetics of inflammatory bowel disease. Gut 2000;47:302-6. (Pubitemid 30489779)
5. Spehlmann ME, Begun AZ, Burghardt J, Lepage P, Raedler A, Schreiber S. Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study. Inflamm Bowel Dis 2008;14:968-76.
6. Jess T, Riis L, Jespersgaard C, et al. Disease concordance, zygosity, and NOD2/CARD15 status: Follow-up of a population-based cohort of Danish twins with inflammatory bowel disease. Am J Gastroenterol 2005;100:2486-92.
7. Nistico L, Fagnani C, Coto I, et al. Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 2006;55:803-8.
8. Bengtson MB, Ronning T, Vatn MH, Harris JR. Irritable bowel syndrome in twins: Genes and environment. Gut 2006;55:1754-9. (Pubitemid 44893573)
9. Mohammed I, Cherkas LF, Riley SA, Spector TD, Trudgill NJ. Genetic influences in irritable bowel syndrome: A twin study. Am J Gastroenterol 2005;100:1340-4. (Pubitemid 40904359)
10. Plaza-Izurieta L, Castellanos-Rubio A, Irastorza I, et al. Revisiting genome wide association studies (GWAS) in coeliac disease: Replication study in Spanish population and expression analysis of candidate genes. J Med Genet 2011;48:493-6.
11. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010;42:1118-25.
12. Anderson CA, Boucher G, Lees CW, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011;43:246-52.
13. Saito YA, Mitra N, Mayer EA. Genetic approaches to functional gastrointestinal disorders. Gastroenterology 2010;138:1276-85.
14. Guo QS, Xia B, Jiang Y, Qu Y, Li J. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J Gastroenterol 2004;10:1069-71. (Pubitemid 38461397)
15. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86-91. (Pubitemid 34747528)
16. Ozen SC, Dagli U, Kilic MY, et al. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease. J Gastroenterol 2006;41:304-10. (Pubitemid 43834372)
17. Juyal G, Prasad P, Senapati S, et al. An investigation of genome-wide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians. PLoS ONE 2011;6:e16565.
18. Williams CN. Does the incidence of IBD increase when persons move from a low- to a high-risk area? Inflamm Bowel Dis 2008;14(Suppl 2):S41-2.
19. Van Speybroeck L. From epigenesis to epigenetics: The case of C. H. Waddington. Ann N Y Acad Sci 2002;981:61-81. (Pubitemid 36127086)
20. Jaenisch R, Bird A. Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat Genet 2003;33 Suppl:245-54. (Pubitemid 36278835)
21. Waterland RA, Kellermayer R, Rached MT, et al. Epigenomic profiling indicates a role for DNA methylation in early postnatal liver development. Hum Mol Genet 2009;18:3026-38.
22. Rishi V, Bhattacharya P, Chatterjee R, et al. CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes. Proc Natl Acad Sci USA 2010;107:20311-6.
23. Jjingo D, Conley AB, Yi SV, Lunyak VV, Jordan IK. On the presence and role of human gene-body DNA methylation. Oncotarget 2012;3:462-74.
24. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992;69:915-26.
25. Waterland RA, Michels KB. Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr 2007;27:363-88. (Pubitemid 351373362)
26. Ficz G, Branco MR, Seisenberger S, et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011;473:398-402.
27. Orr BA, Haffner MC, Nelson WG, Yegnasubramanian S, Eberhart CG. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS ONE 2012;7:e41036.
28. Johnstone RW. Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer. Nat Rev Drug Discov 2002;1:287-99. (Pubitemid 37361445)
29. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997;389:251-60. (Pubitemid 27406632)
30. Margueron R, Reinberg D. Chromatin structure and the inheritance of epigenetic information. Nat Rev Genet 2010;11:285-96.
31. Tan M, Luo H, Lee S, et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 2011;146:1016-28.
32. Gardner KE, Allis CD, Strahl BD. Operating on chromatin, a colorful language where context matters. J Mol Biol 2011;409:36-46.
33. Nie L, Wu HJ, Hsu JM, et al. Long non-coding RNAs: Versatile master regulators of gene expression and crucial players in cancer. Am J Transl Res 2012;4:127-50.
34. Aalto AP, Pasquinelli AE. Small non-coding RNAs mount a silent revolution in gene expression. Curr Opin Cell Biol 2012;24:333-40.
35. Murugan R, Kreiman G. On the minimization of fluctuations in the response times of autoregulatory gene networks. Biophys J 2011;101:1297-306.
36. Moi P, Chan K, Asunis I, Cao A, Kan YW. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci USA 1994;91:9926-30. (Pubitemid 24311921)
37. Khor TO, Huang Y, Wu TY, Shu L, Lee J, Kong AN. Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation. Biochem Pharmacol 2011;82:1073-8.
38. Wang B, Zhu X, Kim Y, et al. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Radic Biol Med 2012;52:928-36.
39. Papp D, Lenti K, Modos D, et al. The NRF2-related interactome and regulome contain multifunctional proteins and fine-tuned autoregulatory loops. FEBS Lett 2012;586:1795-802.
40. Dauncey MJ. Recent advances in nutrition, genes and brain health. Proc Nutr Soc 2012:1-11.
41. Schnabel RB, Baccarelli A, Lin H, Ellinor PT, Benjamin EJ. Next steps in cardiovascular disease genomic research - sequencing, epigenetics, and transcriptomics. Clin Chem 2012;58:113-26.
42. Naguib M, Bie B, Ting AH. Fundamental concepts of epigenetics for consideration in anesthesiology. Curr Opin Anaesthesiol 2012;25:434-43.
43. Scarpa M, Stylianou E. Epigenetics: Concepts and relevance to IBD pathogenesis. Inflamm Bowel Dis 2012;18:1982-96.
44. Sonnenberg A, Melton SD, Genta RM, Lewis AD. Absence of focally enhanced gastritis in macaques with idiopathic colitis. Inflamm Bowel Dis 2011;12:2456-61.
45. Sartor RB. Key questions to guide a better understanding of host-commensal microbiota interactions in intestinal inflammation. Mucosal Immunol 2011;4:127-32.
46. Kellermayer R. Genetic drift. "Omics" as the filtering gateway between environment and phenotype: The inflammatory bowel diseases example. Am J Med Genet A 2010;152A:3022-5.
47. Nagy-Szakal D, Kellermayer R. The remarkable capacity for gut microbial and host interactions. Gut Microbes 2011;2:178-82.
48. Wallace K, Grau MV, Levine AJ, et al. Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev Res (Phila) 2010;3:1552-64.
49. Yuan B, O'Connor TR, Wang Y. 6-Thioguanine and S-methylthioguanine are mutagenic in human cells. ACS Chem Biol 2010;5:1021-7.
50. Kaminsky ZA, Tang T, Wang SC, et al. DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet 2009;41:240-5.
51. Saito S, Kato J, Hiraoka S, et al. DNA methylation of colon mucosa in ulcerative colitis patients: Correlation with inflammatory status. Inflamm Bowel Dis 2011;9:1955-65.
52. Lin Z, Hegarty JP, Cappel JA, et al. Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease. Clin Genet 2011;80:59-67.
53. Nimmo ER, Prendergast JG, Aldhous MC, et al. Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway. Inflamm Bowel Dis 2012;18:889-99.
54. Gonsky R, Deem RL, Landers CJ, et al. Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens. Inflamm Bowel Dis 2011;17:171-8.
55. Harris RA, Nagy-Szakal D, Pedersen N, et al. Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases. Inflamm Bowel Dis 2012, March 29. doi:10.1002/ibd.22956 (E-pub ahead of print).
56. Rosen MJ, Frey MR, Washington MK, et al. STAT6 activation in ulcerative colitis: A new target for prevention of IL-13-induced colon epithelial cell dysfunction. Inflamm Bowel Dis 2011;17:2224-34.
57. Wu F, Guo NJ, Tian H, et al. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2011;17:241-50.
58. Chen Y, Ge W, Xu L, et al. miR-200b is involved in intestinal fibrosis of Crohn's disease. Int J Mol Med 2012;29:601-6.
59. Zahm AM, Thayu M, Hand NJ, Horner A, Leonard MB, Friedman JR. Circulating MicroRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2011;53:26-33.
60. Wigler M, Levy D, Perucho M. The somatic replication of DNA methylation. Cell 1981;24:33-40. (Pubitemid 11157127)
61. Faulk C, Dolinoy DC. Timing is everything: The when and how of environmentally induced changes in the epigenome of animals. Epigenetics 2011;6:791-7.
62. Uauy R, Kain J, Corvalan C. How can the Developmental Origins of Health and Disease (DOHaD) hypothesis contribute to improving health in developing countries? Am J Clin Nutr 2011;94:1759S-64S.
63. Wadhwa PD, Buss C, Entringer S, Swanson JM. Developmental origins of health and disease: Brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med 2009;27:358-68.
64. Beamish LA, Osornio-Vargas AR, Wine E. Air pollution: An environmental factor contributing to intestinal disease. J Crohns Colitis 2011;5:279-86.
65. Malekzadeh F, Alberti C, Nouraei M, et al. Crohn's disease and early exposure to domestic refrigeration. PLoS One 2009;4:e4288.
66. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766-7.
67. Elliott DE, Weinstock JV. Helminth-host immunological interactions: Prevention and control of immune-mediated diseases. Ann N Y Acad Sci 2012;1247:83-96.
68. Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: A systematic review of the literature. Am J Gastroenterol 2011;106:563-73.
69. Tjonneland A, Overvad K, Bergmann MM, et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: A nested case-control study within a European prospective cohort study. Gut 2009;58:1606-11.
70. Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 2010;465:721-7.
71. Carr I, Mayberry JF. The effects of migration on ulcerative colitis: A three-year prospective study among Europeans and first- and second- generation South Asians in Leicester (1991-1994). Am J Gastroenterol 1999;94:2918-22. (Pubitemid 29482758)
72. Li X, Sundquist J, Hemminki K, Sundquist K. Risk of inflammatory bowel disease in first- and second-generation immigrants in Sweden: A nationwide follow-up study. Inflamm Bowel Dis 2011;17:1784-91.
73. Pinsk V, Lemberg DA, Grewal K, Barker CC, Schreiber RA, Jacobson K. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol 2007;102:1077-83. (Pubitemid 46698231)
74. Barreiro-de Acosta M, Alvarez Castro A, Souto R, Iglesias M, Lorenzo A, Dominguez-Munoz JE. Emigration to western industrialized countries: A risk factor for developing inflammatory bowel disease. J Crohns Colitis 2011;5:566-9.
75. Muise AM, Snapper SB, Kugathasan S. The age of gene discovery in very early onset inflammatory bowel disease. Gastroenterology 2012;143:285-8.
76. Kamath BM, Krantz ID, Spinner NB, Heubi JE, Piccoli DA. Monozygotic twins with a severe form of Alagille syndrome and phenotypic discordance. Am J Med Genet 2002;112:194-7. (Pubitemid 35332186)
77. Kellermayer R. Genetic drift. Physiologic noise obscures genotype-phenotype correlations. Am J Med Genet A 2007;143A:1306-7. (Pubitemid 46870095)
78. Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 2002;132:2393S-400S. (Pubitemid 34848114)
79. Waterland RA, Kellermayer R, Laritsky E, et al. Season of conception in rural Gambia affects DNA methylation at putative human metastable epialleles. PLoS Genet 2010;6:e1001252.
80. Khulan B, Cooper WN, Skinner BM, et al. Periconceptional maternal micronutrient supplementation is associated with widespread gender related changes in the epigenome: A study of a unique resource in the Gambia. Hum Mol Genet 2012;21:2086-101.
81. Nagy-Szakal D, Kellermayer R. The remarkable capacity for gut microbial and host interactions. Gut Microbes 2011;2:178-82
82. Kellermayer R, Balasa A, Zhang W, et al. Epigenetic maturation in colonic mucosa continues beyond infancy in mice. Hum Mol Genet 2010;19:2168-76.
83. Kominsky DJ, Keely S, MacManus CF, et al. An endogenously anti-inflammatory role for methylation in mucosal inflammation identified through metabolite profiling. J Immunol 2011;186:6505-14.
84. Schaible TD, Harris RA, Dowd SE, Smith CW, Kellermayer R. Maternal methyl-donor supplementation induces prolonged murine offspring colitis susceptibility in association with mucosal epigenetic and microbiomic changes. Hum Mol Genet 2011;20:1687-96.
85. Nagy-Szakal D, Ross MC, Dowd SE, et al. Maternal micronutrients can modify colonic mucosal microbiota maturation in murine offspring. Gut Microbes 2012;3:426-33.
86. Yan X, Huang Y, Wang H, et al. Maternal obesity induces sustained inflammation in both fetal and offspring large intestine of sheep. Inflamm Bowel Dis 2011;17:1513-22.
87. Innis SM, Dai C, Wu X, Buchan AM, Jacobson K. Perinatal lipid nutrition alters early intestinal development and programs the response to experimental colitis in young adult rats. Am J Physiol Gastrointest Liver Physiol 2010;299:G1376-85.
88. Veenema AH, Reber SO, Selch S, Obermeier F, Neumann ID. Early life stress enhances the vulnerability to chronic psychosocial stress and experimental colitis in adult mice. Endocrinology 2008;149:2727-36. (Pubitemid 351724511)
89. Mulder IE, Schmidt B, Stokes CR, et al. Environmentally-acquired bacteria influence microbial diversity and natural innate immune responses at gut surfaces. BMC Biol 2009;7:79.
90. Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011;331:337-41.
91. Takahashi K, Sugi Y, Nakano K, et al. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. J Biol Chem 2011;286:35755-62.
92. Yin L, Chung WO. Epigenetic regulation of human beta-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria. Mucosal Immunol 2011;4:409-19.
93. Sepulveda AR, Yao Y, Yan W, et al. CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection. Gastroenterology 2010;138:1836-44.
94. Olszak T, An D, Zeissig S, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012;336:489-93.